Despite advances in our understanding of the pathophysiology underlying inflammatory
bowel disease, there remains a significant need for biomarkers that can differentiate …

Inflammatory bowel diseases [IBD] such as Crohn's disease [CD] and ulcerative colitis [UC]
are complex conditions presenting with a wide range of phenotypes. Given major variation …

Crohn's disease and ulcerative colitis represent the two main forms of the idiopathic chronic
inflammatory bowel diseases (IBD). Currently available blood and stool based biomarkers …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Despite major advances in the inflammatory bowel diseases field, biomarkers to enable
personalized and effective management are inadequate. Disease course and treatment …

Biomarkers in inflammatory bowel disease : Current Opinion in Gastroenterology Biomarkers
in inflammatory bowel disease : Current Opinion in Gastroenterology Log in or Register …

The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …

Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme
phenotypes, Crohn's disease [CD] and ulcerative colitis [UC], which both represent …

Precision medicine is part of five focus areas of the Challenges in IBD research document,
which also includes preclinical human IBD mechanisms, environmental triggers, novel …

Background Currently, 2 coprimary end points are used by health authorities to determine
the effectiveness of therapeutic interventions in patients with Crohn's disease (CD) …